Viromed Medical AG: Viromed Medical GmbH and terraplasma medical GmbH
terminate their cooperation with immediate effect

EQS-Ad-hoc: Viromed Medical AG / Key word(s): Miscellaneous
Viromed Medical AG: Viromed Medical GmbH and terraplasma medical GmbH
terminate their cooperation with immediate effect

05-Jul-2024 / 17:30 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation
(EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Viromed Medical AG: Viromed Medical GmbH and terraplasma medical GmbH
terminate their cooperation with immediate effect

Pinneberg, 5 July 2024 - Viromed Medical GmbH, a wholly owned subsidiary of
Viromed Medical AG, and terraplasma medical GmbH have today terminated their
business relation with immediate effect.

As part of the previous cooperation, Viromed Medical GmbH held the exclusive
distribution rights for a cold plasma device developed by terraplasma
medical GmbH in the German-speaking region (Germany, Austria, Switzerland),
with which Viromed Medical GmbH generated slightly less than half of its
annual revenue in the 2023 financial year.

Already in the past, various manufacturers of comparable devices had
expressed interest in cooperating with Viromed Medical GmbH. However, given
the exclusivity agreement with terraplasma medical GmbH, Viromed Medical
GmbH was unable to take advantage of these opportunities. This restriction
now no longer applies, so that Viromed Medical AG sees the possibility of
expanding its sales potential in future by selling its own cold plasma
devices worldwide.

Viromed Medical AG plans to be present on the market with its own cold
plasma product series at the beginning of the fourth quarter of 2024. As a
first step, Viromed Medical AG is planning to enter the European market.

Contact Viromed Medical AG

Uwe Perbandt
CEO
Flensburger Strasse 18
25421 Pinneberg
Germany
Email: kontakt@viromed-medical.de
www.viromed-medical-ag.de


End of Inside Information

---------------------------------------------------------------------------

05-Jul-2024 CET/CEST The EQS Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        Viromed Medical AG
                   Flensburger Straße 18
                   25421 Pinneberg
                   Germany
   Phone:          +49 4101 809960
   E-mail:         kontakt@viromed-medical.de
   Internet:       https://www.viromed-medical-ag.de/
   ISIN:           DE000A3MQR65
   WKN:            A3MQR6
   Listed:         Regulated Unofficial Market in Berlin, Dusseldorf,
                   Hamburg
   EQS News ID:    1940807

End of Announcement EQS News Service
---------------------------------------------------------------------------

1940807 05-Jul-2024 CET/CEST